Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Study of Doxorubicin and Avastin® in Sarcoma.
This study has been terminated.
( The study has been terminated due to low accrual. )
Study NCT00755261   Information provided by Sidney Kimmel Comprehensive Cancer Center

First Received on September 17, 2008.   Last Updated on January 21, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoma
Soft Tissue Sarcoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Connective and Soft Tissue
Interventions listed in this trial
Avastin
Additional drug interventions recognized in this trial
Bevacizumab
Doxorubicin
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antibiotics, Antineoplastic
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Sidney Kimmel Comprehensive Cancer Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services